Atea Pharmaceuticals Inc Cash Flow Reinvestment Rate
Atea Pharmaceuticals Inc cash flow reinvestment rate. Atea Pharmaceuticals Inc (AVIR) has a Cash Flow Reinvestment Rate of 0.00x as of September 2021, reinvesting $4.00K (capex $4.00K ) from operating cash flow of $22.60 Million. Explore AVIR debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Atea Pharmaceuticals Inc (2020–2020)
Cash flow reinvestment rate of Atea Pharmaceuticals Inc from 2020 to 2020. Historical reinvestment intensity for Atea Pharmaceuticals Inc across 1 annual periods. Explore AVIR capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Atea Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2020–2020)
Atea Pharmaceuticals Inc cash flow reinvestment rate by year from 2020 to 2020. Year-by-year capital reinvestment analysis for Atea Pharmaceuticals Inc. For the full cash flow conversion analysis, see AVIR cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.00x | $52.00K | $296.73 Million | $26.00K | — |